These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4777579)

  • 1. The effects of scopolamine and pilocarpine upon the aversive threshold of the rat.
    Houser VP; Van Hart DA
    Pharmacol Biochem Behav; 1973; 1(4):427-31. PubMed ID: 4777579
    [No Abstract]   [Full Text] [Related]  

  • 2. The alteration of aversive thresholds with cholinergic and adrenergic agents.
    Houser VP; Houser FL
    Pharmacol Biochem Behav; 1973; 1(4):433-44. PubMed ID: 4204777
    [No Abstract]   [Full Text] [Related]  

  • 3. Modulation of the aversive qualities of shock through a central inhibitory cholinergic system in the rat.
    Houser VP
    Pharmacol Biochem Behav; 1976 May; 4(5):561-8. PubMed ID: 951435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of cholinergic activity and the aversive threshold in the rat.
    Houser VP; Van Hart DA
    Pharmacol Biochem Behav; 1974; 2(5):631-7. PubMed ID: 4431827
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of scopolamine on three different types of suppressed behavior of rats.
    McKim WA
    Pharmacol Biochem Behav; 1980 Mar; 12(3):409-12. PubMed ID: 7393939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of scopolamine on the reactivity of the albino rat to footshock.
    Feigley DA; Beakey W; Saynisch MJ
    Pharmacol Biochem Behav; 1976 Mar; 4(3):255-8. PubMed ID: 935197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in sensitivity to operant effects of dopaminergic and cholinergic agents following morphine withdrawal in rats.
    Glick SD; Cox RD
    Eur J Pharmacol; 1977 Apr; 42(3):303-6. PubMed ID: 558097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilocarpine: noradrenergic mechanism of a cholinergic drug.
    Mason ST
    Neuropharmacology; 1978 Dec; 17(12):1015-21. PubMed ID: 570647
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of cholinergic agents upon fixated behavior.
    Houser VP; Feldman RS
    Psychopharmacologia; 1971; 21(2):147-56. PubMed ID: 5570195
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of agents that modify muscarinic tone upon behavior controlled by an avoidance schedule that employs signaled unavoidable shock.
    Houser VP; Houser FL
    Psychopharmacologia; 1973; 32(2):133-50. PubMed ID: 4201840
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of scopolamine and physostigmine on fixed-interval behaviour in the rat.
    McKim WA
    Psychopharmacologia; 1974; 39(3):237-44. PubMed ID: 4427990
    [No Abstract]   [Full Text] [Related]  

  • 12. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
    Shannon HE; Bemis KG; Hendrix JC; Ward JS
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1071-7. PubMed ID: 2262893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scopolamine self-administration: cholinergic involvement in reward mechanisms.
    Glick SD; Guido RA
    Life Sci; 1982 Aug; 31(9):909-13. PubMed ID: 7176819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of physostigmine, atropine and scopolamine on behavior maintained by a multiple schedule of food presentation in the mouse.
    Wenger GR
    J Pharmacol Exp Ther; 1979 Apr; 209(1):137-43. PubMed ID: 430373
    [No Abstract]   [Full Text] [Related]  

  • 15. Separating the effects of response rate and reinforcement frequency in the rate-dependent effects of amphetamine and scopolamine on the schedule-controlled performance of rats and pigeons.
    MacPhail RC; Gollub LR
    J Pharmacol Exp Ther; 1975 Aug; 194(2):332-42. PubMed ID: 1151762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of scopolamine on the amnesia induced by electroconvulsive shock.
    Albert DJ; mah CJ; Bose WB
    Pharmacol Biochem Behav; 1974 May; 2(3):443-6. PubMed ID: 4858182
    [No Abstract]   [Full Text] [Related]  

  • 17. Repeated scopolamine injections sensitize rats to pilocarpine-induced vacuous jaw movements and enhance striatal muscarinic receptor binding.
    Baskin PP; Gianutsos G; Salamone JD
    Pharmacol Biochem Behav; 1994 Oct; 49(2):437-42. PubMed ID: 7824562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of scopolamine and physostigmine with ECS and one trial learning.
    Davis JW; Thomas RK; Adams HE
    Physiol Behav; 1971 Mar; 6(3):219-22. PubMed ID: 5125477
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of intrastriatal injections of scopolamine on appetitive behavior.
    Neill DB; Grossman SP
    Pharmacol Biochem Behav; 1973; 1(3):313-8. PubMed ID: 4590740
    [No Abstract]   [Full Text] [Related]  

  • 20. Tolerance to the behavioural effects of physostigmine in rats: lack of importance of behavioural compensation.
    Overstreet DH; Dubas G
    Commun Psychopharmacol; 1978; 2(2):93-8. PubMed ID: 668303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.